These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30441889)

  • 1. Radiomics and radiogenomics of primary liver cancers.
    Jeong WK; Jamshidi N; Felker ER; Raman SS; Lu DS
    Clin Mol Hepatol; 2019 Mar; 25(1):21-29. PubMed ID: 30441889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics in Hepatocellular Carcinoma.
    Sagir Kahraman A
    J Gastrointest Cancer; 2020 Dec; 51(4):1165-1168. PubMed ID: 32844349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics, Radiogenomics, and Next-Generation Molecular Imaging to Augment Diagnosis of Hepatocellular Carcinoma.
    Bell M; Turkbey EB; Escorcia FE
    Cancer J; 2020; 26(2):108-115. PubMed ID: 32205534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Kim JO; Jun DW; Jang K
    Korean J Gastroenterol; 2013 Aug; 62(2):135-9. PubMed ID: 24133714
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.
    Fowler KJ; Sheybani A; Parker RA; Doherty S; M Brunt E; Chapman WC; Menias CO
    AJR Am J Roentgenol; 2013 Aug; 201(2):332-9. PubMed ID: 23883213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation.
    Lo EC; N Rucker A; Federle MP
    Semin Radiat Oncol; 2018 Oct; 28(4):267-276. PubMed ID: 30309637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings.
    Aoki K; Takayasu K; Kawano T; Muramatsu Y; Moriyama N; Wakao F; Yamamoto J; Shimada K; Takayama T; Kosuge T
    Hepatology; 1993 Nov; 18(5):1090-5. PubMed ID: 7693572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.
    Joo I; Kim H; Lee JM
    Korean J Radiol; 2015; 16(1):50-68. PubMed ID: 25598674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamine synthetase, heat shock protein-70, and glypican-3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver.
    Lagana SM; Moreira RK; Remotti HE; Bao F
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):254-7. PubMed ID: 22914614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of CT and MRI in malignant hepatobiliary tumors].
    Kahn T
    Zentralbl Chir; 2000; 125(7):610-5. PubMed ID: 10960971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiogenomics and Radiomics in Liver Cancers.
    Saini A; Breen I; Pershad Y; Naidu S; Knuttinen MG; Alzubaidi S; Sheth R; Albadawi H; Kuo M; Oklu R
    Diagnostics (Basel); 2018 Dec; 9(1):. PubMed ID: 30591628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.
    Chaisaingmongkol J; Budhu A; Dang H; Rabibhadana S; Pupacdi B; Kwon SM; Forgues M; Pomyen Y; Bhudhisawasdi V; Lertprasertsuke N; Chotirosniramit A; Pairojkul C; Auewarakul CU; Sricharunrat T; Phornphutkul K; Sangrajrang S; Cam M; He P; Hewitt SM; Ylaya K; Wu X; Andersen JB; Thorgeirsson SS; Waterfall JJ; Zhu YJ; Walling J; Stevenson HS; Edelman D; Meltzer PS; Loffredo CA; Hama N; Shibata T; Wiltrout RH; Harris CC; Mahidol C; Ruchirawat M; Wang XW;
    Cancer Cell; 2017 Jul; 32(1):57-70.e3. PubMed ID: 28648284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for Hepatobiliary Cancers.
    Nault JC; Villanueva A
    Hepatology; 2021 Jan; 73 Suppl 1():115-127. PubMed ID: 32045030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?
    Hesketh RL; Zhu AX; Oklu R
    Am J Clin Oncol; 2015 Aug; 38(4):431-6. PubMed ID: 25238287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review.
    Zhang ZG; Chen Y; Ji R; Zhao YJ; Wang J; Robinson L; Chen XP; Zhang L
    BMC Cancer; 2018 Oct; 18(1):1046. PubMed ID: 30373546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined hepatocellular-cholangiocarcinoma].
    Han JK; Kim SH; Kim SJ
    Korean J Hepatol; 2007 Mar; 13(1):112-5. PubMed ID: 17380083
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
    Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J
    Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biological diagnosis and gene therapy of hepatocellular carcinoma: the present status.
    Ji JF
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):724-5. PubMed ID: 12914006
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterochronous development of intrahepatic cholangiocellular carcinoma following hepatocellular carcinoma in a hepatitis B virus carrier.
    Shiozawa K; Ishii K; Mori T; Takamura N; Ikehara T; Shinohara M; Kawafune T; Sumino Y; Nonaka H
    Intern Med; 2001 Jul; 40(7):624-30. PubMed ID: 11506304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.